Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: A case series

From December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of coronavirus disease 2019 (COVID-19) that has frequently overwhelmed health care systems due to the high number of patients requiring admission to an intensive care unit (ICU).

Saved in:
Bibliographic Details
Published inCritical care and resuscitation Vol. 22; no. 4; pp. 388 - 390
Main Authors Morselli, Federica, Vitali, Giordano, Brioschi, Elena, Di Terlizzi, Gaetano, Belletti, Alessandro, Lombardi, Gaetano, Senarighi, Giacomo, Neto, Ary Serpa, Zangrillo, Alberto, Landoni, Giovanni
Format Journal Article
LanguageEnglish
Published Elsevier 01.12.2020
Subjects
Admission and discharge
Angiotensin II
Care
Coronavirus infections
COVID-19 (Disease)
Diagnosis
Intensive care units
Patients
Research Letters
SARS (Disease)
Online AccessGet full text

Cover

More Information
Summary:From December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of coronavirus disease 2019 (COVID-19) that has frequently overwhelmed health care systems due to the high number of patients requiring admission to an intensive care unit (ICU).
Bibliography:Critical Care and Resuscitation, Vol. 22, No. 4, Dec 2020: 388-390
CCR.jpg
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1441-2772
2652-9335
DOI:10.51893/2020.4.rl1